Full Professor. Pharmaceutical nanoscience and pharmaceutical regulation. University of the Western Cape
Cape Town, South Africa
Joined November 2008
- Tweets7.6K
- Following677
- Followers1.1K
- Likes18.3K
Admire Dube retweeted
China's drug regulator said on Monday it has approved a CARsgen Therapeutics treatment for stomach cancer, a new milestone for CAR-T therapies, which engineer patients' immune cells to recognise and kill cancer cells. reut.rs/4eVwCHL reut.rs/4eVwCHL
Admire Dube retweeted
Explore the latest findings from the @AinslieLab “Nanoparticle vaccine formulations for dengue virus” in RSC Pharmaceutics with first author PhD Candidate Connor Murphy🔗doi.org/10.1039/D6PM00015K
@UNCPharmacy
Admire Dube retweeted
My thanks to Commissioner @hadjalahbib for joining @Chikwe_I, @WHO team and #Ebola responders in Bunia, #DRC. We need solidarity, collaboration and all support for the affected communities to end this outbreak.
xitter.gq/Chikwe_I/status/206365…
While others are locking their borders, @hadjalahbib, you have chosen to come to Bunia #DRC
While others have chosen distance, you have chosen presence
This visit reflects not only the leadership of DRC but also @EU_Commission leadership in standing alongside partners.
Admire Dube retweeted
Standardized lung function reference values in rats for translational respiratory research: Communications Biology, Published online: 24 April 2026; doi:10.1038/s42003-026-10123-0Clinical-style reference equations for rat lung function enable… dlvr.it/TSpQ58
Admire Dube retweeted
Remembering Peter H. Raven, a visionary botanist who transformed our understanding of plant diversity.
go.nature.com/4fbSUpn
Admire Dube retweeted
We’re very close to a new breakthrough in science. Clinical trials for new tuberculosis #TB vaccines remain on track, and will deliver efficacy results within the next two years showing how well the vaccines work.
TB is still the world’s deadliest infectious disease, yet no new vaccine has been approved in over 100 years.
As these clinical trials proceed, we need to ensure that the novel TB vaccines, will be available equitably across the world to meet the global target of reducing new cases by 80% by 2030.
Admire Dube retweeted
Molecular modelling–driven formulation design for targeted pulmonary drug delivery; doi.org/10.1016/j.ijpharm.20… #NICM Health Research Institute, @westernsydneyu @Aerogen @ChitkaraU @DrKeshavRajPau1 @Mangesh_MPK @UTSFEIT
Admire Dube retweeted
#WorldTBDay: UWC MSc Pharmaceutical Sciences student Athembile Centane is exploring nanoparticles that help the immune system better recognise and fight TB bacteria. Learn more on Tuesday, 24 March, at the grass between A and B Block. #IAmUWC
Admire Dube retweeted
Check out the March 2026 Special Issue of @DDTReMedia (EiC @MariaJ_Alonso) on Engineering Access to the Brain: Nanotechnologies at the Interface of Delivery, Neurology, and Immunotherapy
Guest Editors: Olivia M. Merkel, Shang-Hsiu Hu, Cristina Fornaguera
link.springer.com/journal/13…
Admire Dube retweeted
Thrilled to share our new @DDTReMedia Editorial: rdcu.be/e1vp2🎉@juan_avetrece and I reflect on RNA delivery milestones/challenges, with views from leaders @MJMitchell_Lab, @peer_lab, @YvonnePerrie, @DJSiegwart & MJAlonso. Grateful to EiC MJAlonso for the opportunity. – at Guimarães, Portugal
Admire Dube retweeted
ADDR Open Access: Repurposing the bacterial surface display technology for drug delivery.
By Jiahe Li & coworkers @UMBME
#SyntheticBiology #microbiome
kwnsfk27.r.eu-west-1.awstrac…
Admire Dube retweeted
.@WHO has designated national regulators in Canada, Japan and the United Kingdom as WHO-listed authorities, meaning they meet the highest international standards for regulation of medical products: who.int/news/item/07-08-2025…
Admire Dube retweeted
🚨 New Collaboration!
The @MycetomaRC – Univ. of Khartoum teams up with @UWConline -College of Pharmacy to fight #eumycetoma using cutting-edge nanotech!
Led by Prof. Admire Dube & Dr. Rami Ahmed, the project aims to boost treatment outcomes for this NTD. 🌍🧪
#NTD #AfricaScience
Admire Dube retweeted
[APPLY] Applications for the 2026 at UWC are now open. Undergraduate applications for 2026 will close on 30 Sept 2025. Selected Postgraduate programmes will close earlier. Apply now and take the first step towards your future: bit.ly/UWC-Apply.
#IAmUWC #ChooseUWC
Admire Dube retweeted
Advanced peptide nanoparticles enable robust and efficient delivery of gene editors across cell types.
| Samir E.L. Andaloussi @karolinskainst |
[Open Access]
#GeneEditorDelivery #PeptideNanoparticle #CellPenetratingPeptide
kwnsfk27.r.eu-west-1.awstrac…
Admire Dube retweeted
Yes.
Writing is not a second thing that happens after thinking. The act of writing is an act of thinking. Writing *is* thinking.
Students, academics, and anyone else who outsources their writing to LLMs will find their screens full of words and their minds emptied of thought.
Admire Dube retweeted
Contributed to an interesting study @dariog_helsinki on the safety assessment of engineered nanomaterials,bridging data gaps & revealing toxicity mechanisms related to environmental nanomaterial exposures,integrating expert knowledge w computational models
doi.org/10.1021/acs.est.5c00…
